#ASCO24 is underway and we're excited to connect with the oncology community! Stop by booth #28115 to learn more about our end-to-end precision oncology solutions and our work to disrupt the paradigm of cancer monitoring.
Guardant Health’s Post
More Relevant Posts
-
With the prevalence of cancer and the rapid increase in cancer treatment costs, a value-based approach is critical to ensure the best possible cancer care without unnecessary spending. Learn how eviCore’s Oncology Value-based Pathways program is helping: https://bit.ly/4aHbOj5
-
-
The speed of innovation and steepness of cost trend in the oncology drug space is at an all-time high. Using a collaborative model like ours to increase the use of higher-value (which, by the way, does not always mean lowest cost) treatment regimens is one of many important tools we can deploy to address this need.
With the prevalence of cancer and the rapid increase in cancer treatment costs, a value-based approach is critical to ensure the best possible cancer care without unnecessary spending. Learn how eviCore’s Oncology Value-based Pathways program is helping: https://bit.ly/4aHbOj5
-
-
It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://lnkd.in/gRc_wcPh Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment
-
In light of significant strides in cancer treatment and prevention, a diagnosis no longer carries the grim prognosis it once did. Join us at #SXSW2024 for our “Rebranding Cancer” panel where experts will delve into reshaping the perception of cancer from one of fear to a more accurate portrayal of the advancements in oncology. Learn more about our panel and download the Oncology Inflection here: https://bit.ly/3SPZBkd
-
Although, certain habits may increase your chances of acquiring cancer, abstaining from them doesn’t eliminate your risks. Discover the truth about cancer with our expert, Dr. Surender Kumar Dabas, Vice Chairman, Oncology. Learn why regular check-ups are your best defense against cancer. #CancerAwareness #Prevention #Oncology #BLKMaxSuperSpecialityHospital
-
It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/3KWYk7p Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment
-
-
MSD actively participates in the public dialogue for EU’s Beating Cancer Plan and the need for a National Plan for Cancer in Greece. For the 3rd consecutive year, #MSDGreece took part in the "Economist Impact" event "Greece's agenda to combat cancer", under the auspices of HeSMO, by submitting proposals to improve the lives of oncology patients. Learn more here: https://bit.ly/3LDw7mF #MSDGreece #EUBeatingCancerPlan #EconomistImpact
-
-
It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/4ewD8CF Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment
-
-
+++ #news +++ This year’s #ASCO24 theme focuses on uncovering a world of inspiration. Every year we are excited to join the oncology community at this crucial congress. At this year’s meeting we will be highlighting how #TeamBayer is inspired by those affected by cancer to drive innovative research in oncology. Learn more about Bayer’s commitment to transforming cancer care and addressing unmet patient needs across difficult-to-treat cancers: https://lnkd.in/ekY-krjA
-
With more than 22,000 registrants and more than 240 clinical trials presented, the annual American Association for Cancer Research (AACR) conference had a lot happening! Read some of the highlights and key takeaways from Meredith Manuel, Executive Director, Catalyst Oncology Consulting. She provides her take on sessions about accelerated approvals, cancer vaccines, and big data and AI in oncology studies. You don't want to miss it! https://lnkd.in/eZvS2PpA #AACR24 #BigData #PrecisionMedicine #OncologyConsulting
-
